Momentum Life Sciences Announces Strategic Growth Investment from Parthenon Capital
Momentum Life Sciences (“Momentum” or the “Company”), a leading commercialization platform offering patient- and provider-facing solutions that support initiation and adherence for specialty therapies, announced a strategic investment from Parthenon Capital, a growth-oriented private equity firm with a long history of supporting innovative companies in healthcare solutions and technology. Following the investment, Momentum’s existing leadership team will continue as significant shareholders in the Company.
